In comparison to LLC1-HER2, the CT26-HER2 tumor was characterized by an antitumoral Th1 signature and high levels of IFN-I, -II, ISGs, co-stimulatory molecules, and TNFs. This evidence concerns the gene ERBB2 and neoplasm.